# Bryan Johnson's Blueprint protocol: what he does, what his numbers mean and what is worth copying

> The diet, workouts, sleep, supplements and nine prescription drugs in Blueprint as he publishes them, what he tried and dropped, which of his famous numbers are drug-driven, and which parts have real evidence behind them.

*heart · The LifeFrom Team · November 19, 2026 · 11 min read*
Canonical: https://lifefrom.ai/blog/bryan-johnson-blueprint

## The distinctions

- **His inputs vs his outputs.** Blueprint's inputs are habits and drugs: what he eats, when he sleeps, how he trains and what he is prescribed. Its outputs are lab numbers and pace-of-ageing scores. The headline outputs are the least transferable part. His low LDL and ApoB come with evolocumab, a drug that took median LDL to 30 mg/dL in its main trial [[3]], and his pace-of-ageing scores come from one person with no control group; the best randomised result for any lifestyle change, CALERIE's calorie restriction, moved DunedinPACE by only 2 to 3% [[5]]. The inputs with the strongest evidence, regular exercise [[2]] and enough sleep [[8]], are the cheapest to copy.

---

Bryan Johnson sold the payments company Braintree in 2013 and since 2021 has spent millions of dollars a year measuring his body and adjusting his routine to the data; he told Bloomberg Businessweek in 2023 that the figure was about $2 million. He calls the routine Blueprint, publishes it free at protocol.bryanjohnson.com and writes, "I think it's the best health protocol in the world" [1]. The 2025 Netflix documentary Don't Die brought Blueprint to a mainstream audience. The parts with the strongest evidence, exercise, steady sleep and mostly plant-based food, cost little and match US guidelines. His most quoted lab numbers come largely from prescription drugs, and his pace-of-ageing scores come from one person with no control group.

**Blueprint in brief**
- Blueprint is about 2,250 calories a day, 130 g of protein, the last meal around noon, about 6 hours of exercise a week, bed at 8:30 pm and a blood draw every 3 to 6 months [1].
- He publishes nine prescription drugs, including evolocumab (Repatha) for cholesterol, metformin, acarbose and empagliflozin for blood sugar, candesartan for blood pressure and two thyroid hormones [1].
- His cholesterol plan is a drug. Evolocumab lowers LDL cholesterol and ApoB (a count of the cholesterol-carrying particles that build plaque); in the FOURIER trial it took median LDL from 92 to 30 mg/dL [3].
- The parts with the strongest evidence, exercise and sleep, cost nothing and match US guidelines [2] [8].

### What Blueprint is

## Bryan Johnson's Blueprint protocol in one minute

Johnson was born in 1977 and is 49 in late 2026. Blueprint started in 2021 with a team of doctors measuring his organs and a rule that the data decides what he eats, how he trains and when he sleeps, overriding his own preferences. He posts the routine, many of his results and his pace-of-ageing scores in public, which makes Blueprint unusually easy to inspect.

It is also a trial with one participant, no control group and dozens of changes made at once. When one of Johnson's numbers improves, there is no way to say which part of Blueprint did it, or whether a person with different genes, age and budget would see the same. Every number below has that limit.

## What does Bryan Johnson eat?

The current published Blueprint diet sets about 2,250 calories a day, which Johnson describes as about 10% below his needs, split as follows [1]. He eats his meals early and stops eating around noon. Older articles quote 1,977 calories and a fully vegan menu; those numbers come from earlier versions of the protocol, which is why the internet disagrees with itself.

| Part of the diet | Blueprint (published 2026) | Share of calories |
| --- | --- | --- |
| Calories | About 2,250 a day | About 10% under his needs |
| Protein | 130 g, including collagen peptides | About 25% |
| Carbohydrate | 206 g | About 35% |
| Fat | 101 g, mostly extra virgin olive oil and nuts | About 40% |
| Last meal | Around noon | Not applicable |

The staples are well known from his videos: the Super Veggie (black lentils, broccoli, cauliflower, mushrooms, garlic and ginger, with olive oil), a nut and berry bowl he calls Nutty Pudding, and a morning drink with creatine and prebiotic fibre. The parts of that menu with evidence behind them are a lot of fibre, legumes most days, olive oil as the main fat and enough protein; in the PREDIMED trial of Spanish adults at high heart risk, a Mediterranean diet with extra olive oil or nuts cut a combined count of heart attacks, strokes and heart deaths compared with advice to eat a lower-fat diet [13]. The noon cut-off and the 10% calorie deficit are his personal choices, and the section on his pace-of-ageing scores below shows how small the measured effect of eating less has been.

## Exercise, sleep and the daily routine

Johnson wakes around 5 am, trains in the early morning, eats his last meal near noon and is in bed by 8:30 pm [1]. Across a week that adds up to about 6 hours of exercise: three strength sessions, three cardio sessions and work on flexibility and balance [1]. Of everything in Blueprint, this is the part closest to mainstream medicine.

| Habit | Blueprint | Mainstream guideline |
| --- | --- | --- |
| Aerobic exercise | About 150 min of Zone 2 (easy, steady effort where you can still talk) plus 75 min vigorous a week | 150 to 300 min moderate or 75 to 150 min vigorous a week (HHS 2018) [[2]] |
| Strength training | 3 sessions a week | 2 or more days a week (HHS 2018) [[2]] |
| Sitting | Moves every 30 minutes | Sit less; any movement counts (HHS 2018) [[2]] |
| Sleep | In bed by 8:30 pm, same time daily, screens off an hour before | 7 or more hours a night (AASM and Sleep Research Society, 2015) [[8]] |

Johnson's aerobic total sits at the top of the US guideline range, and his strength work goes beyond its minimum [2]. Those guidelines say substantial benefit comes from 150 to 300 minutes of moderate activity a week, with more benefit beyond that, so a person doing 150 minutes and two strength days already has a large share of what his training buys [2]. The [heart rate zones calculator](/calculators/heart-rate-zones) finds your own Zone 2, and the [VO2 max calculator](/calculators/vo2-max) estimates the fitness number he tracks without a lab. His sleep rules (a fixed bedtime, a dark cool room, no screens late) are standard sleep hygiene; our guide to [deep sleep](/learn/deep-sleep) covers what changes sleep quality.

> **Build up training gradually.** Chest pain, pressure or unusual breathlessness during exercise means stop and get same-day care; call 911 if it is severe or does not settle with rest. If you have heart disease, diabetes or have been inactive for years, talk to a clinician before jumping to Johnson's 6 hours a week.

## The supplements and prescription drugs he takes

His published supplement routine is shorter than the old "100 pills a day" headlines suggest: a longevity drink mix with 5 g of creatine, prebiotic fibres (galactooligosaccharides, inulin and arabinogalactan), collagen peptides, a multinutrient capsule, an antioxidant capsule, [ashwagandha](/compounds/ashwagandha) with [rhodiola](/compounds/rhodiola) and EPA/DHA fish oil [1]. Most are his own Blueprint brand. Creatine has the strongest trial evidence of the stack, for muscle strength alongside training [17]; the others range from modest to untested for ageing. Older lists and other sites name NMN as a core longevity supplement, but no human trial has shown that it slows ageing.

The prescription list matters more, because it explains several of his famous numbers. Blueprint lists these drugs [1]:

| Drug | What it is usually prescribed for | What it can move on a blood test |
| --- | --- | --- |
| Evolocumab (Repatha), every other week | High LDL cholesterol; an injection that helps the liver clear LDL from the blood (a PCSK9 inhibitor) | LDL cholesterol by more than half, ApoB by roughly half |
| Metformin, 6 weeks on and 6 off | Type 2 diabetes | Glucose and HbA1c (average blood sugar over about three months); can lower [vitamin B12](/biomarkers/vitamin-b12) over time |
| Acarbose | Type 2 diabetes; slows starch digestion | After-meal glucose |
| Empagliflozin (Jardiance) | Type 2 diabetes, heart failure, kidney disease | Glucose and HbA1c; sugar in the urine by design |
| Candesartan | High blood pressure | Blood pressure; potassium and creatinine |
| Tadalafil | Erectile dysfunction, enlarged prostate | Little on routine labs |
| Armour Thyroid and levothyroxine | [Hypothyroidism](/conditions/hypothyroidism), diagnosed at 21, his page says | TSH, free T4 and free T3 |
| Minoxidil (oral, low dose) | Hair loss (off-label, meaning a use the drug is not approved for) | Little on routine labs |

> **These drugs need a prescriber.** Every drug on Johnson's list has side effects and interactions, and several (metformin, acarbose, empagliflozin) are glucose-lowering drugs built for people with diabetes. Do not copy the list or buy any of these drugs online. Shakiness, sweating and confusion while taking a glucose-lowering drug can be low blood sugar and need prompt care; call 911 if the person is confused and cannot safely eat or drink.

If you want to know which supplements a blood result can justify, [supplements based on your blood test](/learn/supplements-based-on-your-blood-test) works through it result by result.

## What he tried and dropped

Blueprint is also a record of things that did not hold up, and that record is one of its more useful parts. Even with near-unlimited testing, most of Johnson's exotic experiments showed no measurable benefit in his own data.

| Intervention | When | Status |
| --- | --- | --- |
| Young plasma infusions, including plasma from his teenage son | Stopped July 2023 | He said he detected no benefits; the FDA warned in 2019 that young-donor plasma has no proven clinical benefit [[14]] |
| Rapamycin | About five years, stopped in 2024 | In a 2024 post on X he cited skin and soft-tissue infections, higher glucose and lipids and a raised resting heart rate |
| Cerebrolysin, a brain peptide drug | Tried and dropped | Daily injections for three months, with no measurable effect, his page says [[1]] |
| Follistatin gene therapy (meant to build muscle), in Honduras | One-off, 2023 | No controlled outcome data published |

Rapamycin is the instructive one. It is popular among longevity enthusiasts, yet the person with the most testing of any rapamycin user reported side effects and no clear gain. Our [rapamycin page](/compounds/rapamycin) sums up the evidence: "Rapamycin extended median life by up to 26 percent in preclinical studies (Miller 2014), but human trials so far only show that weekly low doses are tolerable for about a year; no human study has measured lifespan."

### What his numbers mean

## Bryan Johnson's blood tests and his numbers

Blueprint has him drawn every 3 to 6 months [1]. The markers he discusses most fall into these groups:

- Heart: ApoB, LDL cholesterol, [Lp(a)](/biomarkers/lipoprotein-a) (an inherited cholesterol particle) and triglycerides.
- Metabolic: HbA1c, fasting glucose and [fasting insulin](/biomarkers/fasting-insulin).
- Inflammation: hs-CRP, a sensitive inflammation test.
- Liver and kidney: ALT, AST, [GGT](/biomarkers/ggt), creatinine, [cystatin C](/biomarkers/cystatin-c) and eGFR.
- Hormones: [TSH](/biomarkers/tsh), free T4, free T3 and testosterone.
- Nutrients: ferritin, vitamin D, [vitamin B12](/biomarkers/vitamin-b12) and the omega-3 index.

His protocol page does not publish a table of his results. It reports an hs-CRP "below detectable levels" and a 235% rise in vitamin D during hyperbaric oxygen sessions, without the starting or ending level [1]. The figures that circulate online, such as an ApoB of 52 mg/dL, an LDL of 35 mg/dL, a ferritin of 20 ng/mL and a vitamin D of 134 ng/mL, come from testing-company blogs that give no dated result and do not agree with each other: one puts his LDL at 35 mg/dL, another at 45. Treat them as rough. The table below shows what each marker means and how his routine pushes it.

| Marker | Usual US line or guideline goal | What his routine does to it |
| --- | --- | --- |
| ApoB | Below 65 mg/dL is the ESC/EAS goal for very high risk [[4]] | Evolocumab lowers it, by roughly half |
| LDL cholesterol | Below 55 mg/dL (1.4 mmol/L) is the ESC/EAS goal for very high risk [[4]] | Evolocumab lowers it; FOURIER reached a median of 30 mg/dL [[3]] |
| HbA1c | [Prediabetes](/conditions/prediabetes) starts at 5.7% (ADA) [[9]] | Metformin, acarbose and empagliflozin all push it down |
| hs-CRP | Below 1 mg/L marks lower heart risk (AHA/CDC) [[10]] | His page reports it below detectable levels [[1]]; one reading can [jump with a cold](/compare/hs-crp-vs-crp) |
| Ferritin | Many labs print a low cutoff between 15 and 30 ng/mL | The quoted figure, about 20 ng/mL, sits near the low end |
| Vitamin D (25-OH) | Most US labs flag above 100 ng/mL; toxicity is usually reported above about 150 ng/mL [[12]] | His page reports a 235% rise [[1]]; the quoted figure is about 134 ng/mL |

ESC/EAS is the joint European heart and cholesterol guideline. Its "very high risk" goals are for people who already have heart disease or a similar risk, so your own target depends on your own risk.

Low ApoB and LDL are the clearest case of a drug-driven output. In the FOURIER trial of 27,564 people with heart disease, evolocumab cut LDL cholesterol by 59% on top of statins and lowered heart attacks and strokes over about two years [3]. Johnson takes the same drug, so a low LDL in him shows the drug works in him; a reader without it has no reason to expect LDL in the 30s from food and exercise alone. [ApoB vs LDL](/compare/apob-vs-ldl) explains why ApoB is the sharper of the two.

**92 to 30 mg/dL** median LDL cholesterol before and after 48 weeks of evolocumab, a 59% drop (FOURIER trial, 27,564 people with heart disease, all on statin therapy [[3]])

If your own LDL or ApoB is high, ask your clinician about your overall heart risk. The usual first drug is a [statin](/compounds/statins), [foods that lower cholesterol](/learn/foods-that-lower-cholesterol) covers what diet can do, and [high cholesterol](/conditions/high-cholesterol) explains the targets.

## Two of his quoted numbers not to aim for

A ferritin near 20 ng/mL is close to the low cutoff many labs print, and the [ferritin](/biomarkers/ferritin) page explains how to read it beside iron and transferrin saturation. If yours is under about 30 ng/mL, ask your clinician for a full iron panel ([iron studies, explained](/learn/iron-studies-explained)) before taking iron. In a man or a post-menopausal woman, low ferritin needs a clinician to find the cause, which can be blood loss from the gut; [iron deficiency](/conditions/iron-deficiency) covers the causes and treatment.

A vitamin D around 134 ng/mL is above the top of most US lab ranges and not far from the level of about 150 ng/mL where vitamin D toxicity is usually reported [12]. The Endocrine Society's 2024 guideline does not endorse any target vitamin D level and advises against routine testing in healthy adults under 75 [11], so there is no evidence that a level this high adds anything.

> **High vitamin D can raise calcium.** Nausea, vomiting, heavy thirst, passing a lot of urine, confusion or weakness while taking high-dose vitamin D can mean a high blood calcium. That needs a clinician promptly, the same day if you feel confused or very unwell.

## Beyond blood: scans and measurements

Johnson adds a yearly whole-body MRI, a DEXA scan for body fat and bone, VO2 max testing, a continuous glucose monitor, and skin, eye and dental checks. They differ a lot in how much evidence sits behind them.

- Whole-body MRI: the American College of Radiology does not recommend it for people without symptoms, because incidental findings lead to more scans and procedures [18].
- DEXA: measures fat, lean mass and bone density. Johnson repeats it, and as [what a DEXA scan shows](/learn/dexa-scan-explained) puts it, "A change counts as real only when it is bigger than the clinic's least significant change."
- Continuous glucose monitor: useful in diabetes, less clear without it. [CGM for non-diabetics](/learn/cgm-for-non-diabetics) notes that "It can't diagnose prediabetes or insulin resistance, and there are no agreed CGM targets for people without diabetes."
- Coronary calcium score: a cheap CT scan with guideline support for adults whose heart risk is uncertain, and one Johnson does not headline; see the [coronary calcium score](/learn/coronary-calcium-score).

## Is he ageing slower? What his pace-of-ageing scores mean

Johnson's headline age number is DunedinPACE, an epigenetic clock: a blood test that reads DNA methylation (chemical tags on DNA) and estimates ageing from them. DunedinPACE reports a pace-of-ageing score, where 1.0 means one year of biological change per calendar year [7]. He has posted scores well below 1.0, and the figures quoted in coverage vary with the date and the lab.

Three facts put those scores in proportion. First, in the CALERIE trial, adults of normal to slightly high weight who cut calories by about 12% for two years slowed DunedinPACE by 2 to 3% compared with controls and did not move two other epigenetic clocks, GrimAge and PhenoAge [5]. The authors called the effect small, while noting that small shifts could matter across a whole population. Second, many epigenetic clocks are noisy when the same blood is tested twice:

> Here we show technical noise produces deviations up to 9 years between replicates for six prominent epigenetic clocks, limiting their utility.
> (Higgins-Chen et al., Nature Aging 2022 [[6]])

That finding is about six older clocks, not DunedinPACE, which was built from methylation sites that repeat well and is steadier [7]. Even so, a change of a few hundredths between two tests can be noise. Third, the organ ages in his reports, such as a vascular function he lists as "late teen / early 20s" [1], are model estimates built from blood and imaging; none of them measures the organ directly, and no trial has shown that improving them lengthens life.

> **How to read a pace-of-ageing score.** A DunedinPACE of 1.0 means one year of biological change per year; below 1.0 is slower. Compare two results only when they come from the same lab and the same method, look for a change that holds across several tests, and remember that the largest effect seen in a randomised trial, CALERIE's calorie restriction, was a few percent [5].

### What is worth copying

## Does Blueprint work? Each part graded against the evidence

Graded one component at a time, the cheapest parts of Blueprint have the most evidence behind them.

| Blueprint component | Evidence in humans | Source |
| --- | --- | --- |
| 150+ minutes of activity and 2+ strength days a week | Strong | Physical Activity Guidelines for Americans, 2018 [[2]] |
| 7 or more hours of sleep on a fixed schedule | Strong | AASM and Sleep Research Society consensus, 2015 [[8]] |
| Lowering LDL and ApoB in people at high risk | Strong for fewer heart attacks and strokes | FOURIER, NEJM 2017 [[3]]; ESC/EAS 2019 [[4]] |
| Blood pressure control (he takes candesartan) | Strong for fewer heart events and deaths in people with high blood pressure at raised heart risk | SPRINT, NEJM 2015 [[16]] |
| Mediterranean-style eating with olive oil, nuts and legumes | Moderate | PREDIMED, NEJM 2018 [[13]] |
| Omega-3 fish oil for high triglycerides | Moderate for lowering triglycerides at prescription doses; mixed for heart events | AHA science advisory, 2019 [[15]] |
| Modest calorie restriction | Small effect on one pace-of-ageing score | CALERIE, Nature Aging 2023 [[5]] |
| Metformin or acarbose to slow ageing without diabetes | Unproven; the TAME trial has not reported | No finished outcome trial |
| Rapamycin, young plasma, gene therapy | Unproven or no benefit | He stopped two of the three himself |
| Epigenetic clocks as the scoreboard | Noisy between repeat tests for many clocks | Higgins-Chen, Nature Aging 2022 [[6]] |

The risks are real too. Nine prescription drugs bring nine sets of side effects and interactions, a ferritin near 20 and a vitamin D above 100, as they are quoted for him, are results that usually lead a clinician to look closer, and a routine this rigid is hard to keep for most people with jobs and families.

## How to borrow the useful parts of Blueprint without his budget

The parts of Blueprint with the strongest evidence cost little or nothing. A version a normal person can keep looks like this.

1. **Move most days**: Aim for at least 150 minutes of moderate activity a week plus two strength days, the US guideline floor [2], and build up from wherever you are now.
2. **Protect sleep**: Keep a fixed bedtime and wake time with 7 or more hours asleep [8]; the exact hour matters less than keeping it steady.
3. **Copy his plate; the clock is optional**: Mostly plants, legumes most days, olive oil and nuts as the main fats, and [enough protein for your size](/calculators/protein). Finishing by noon is a personal choice.
4. **Read the markers you already have**: If your clinician orders labs, the ones that track the same risks as Johnson's are ApoB, Lp(a) once in a lifetime, HbA1c, fasting insulin, hs-CRP, a [lipid panel](/learn/how-to-read-your-lipid-panel), liver and kidney chemistry, ferritin and vitamin D. Not sure what to ask for? [What blood tests should I get](/learn/what-blood-tests-should-i-get) lists them by age and goal.
5. **Retest only what you change**: After a change in diet or training, a recheck in about three months shows whether it worked; after a prescription change, your prescriber sets when to retest. Supplement only what a result shows you lack, with your clinician.

Compare your results with your own earlier results. Johnson's numbers come with a team, a budget and a prescription list, and a single reading of yours tells you less than three readings in a row; [why a trend beats a single reading](/learn/trends-beat-single-readings) explains why. [Reference ranges, explained](/learn/reference-ranges-explained) covers where the lab's printed range comes from, and [LifeFrom for longevity](/for/longevity) lists the related markers and guides.

## Bryan Johnson vs Peter Attia: two longevity playbooks

Peter Attia, the physician who wrote Outlive, measures far less than Johnson and adds no experimental drugs; as our [Peter Attia's blood tests](/blog/peter-attia-blood-tests) guide puts it, "His tests are mostly mainstream, his targets are his own." The two agree on the core, lower ApoB, protect metabolic health, train hard and sleep well, and Attia's version is the easier one to copy because most of it is a standard blood draw.

[Drop in your lab report and see every marker explained in plain words, placed on the body, against your lab's range. It's read on your device: nothing is uploaded and nothing is kept.](https://lifefrom.ai/read/blood-test)

## Common questions

**What blood tests does Bryan Johnson do?**

Johnson has blood drawn every 3 to 6 months and tracks heart markers (ApoB, LDL cholesterol, Lp(a), triglycerides), metabolic markers (HbA1c, fasting glucose and insulin), inflammation (hs-CRP), liver and kidney chemistry, thyroid and sex hormones, and nutrients such as ferritin, vitamin D and B12. He adds epigenetic tests such as DunedinPACE. His protocol page does not publish a results table; the figures quoted online (for example an ApoB of 52 mg/dL) come from third-party blogs and disagree with each other. His low LDL and ApoB come with evolocumab (Repatha), a cholesterol drug.

**How much does Bryan Johnson spend on Blueprint?**

Johnson told Bloomberg Businessweek in 2023 that he spends about $2 million a year, mostly on his medical team, testing and imaging; his protocol page says millions of dollars. The parts of Blueprint with the strongest evidence, regular exercise, 7 or more hours of sleep and a mostly plant-based diet with olive oil and legumes, cost little or nothing.

**What does Bryan Johnson eat in a day?**

About 2,250 calories, with 130 g of protein, 206 g of carbohydrate and 101 g of fat, mostly from extra virgin olive oil and nuts. Staples include the Super Veggie (black lentils, broccoli, cauliflower, mushrooms, garlic and ginger), a nut and berry bowl called Nutty Pudding, collagen peptides and a morning drink with creatine and prebiotic fibre. His last meal is around noon.

**What time does Bryan Johnson go to bed?**

He is in bed by 8:30 pm at the same time every day, with screens off an hour before. He wakes around 5 am and trains in the early morning. The useful part to copy is the fixed schedule and 7 or more hours of sleep, not the exact hour.

**What is Bryan Johnson's biological age?**

His headline measure is DunedinPACE, a pace-of-ageing score where 1.0 means one year of biological change per calendar year. He has posted scores well below 1.0, and the figures quoted vary by date and lab. These come from one person with no control group, and in the CALERIE trial two years of calorie restriction slowed DunedinPACE by only about 2 to 3%.

**Why did Bryan Johnson stop taking rapamycin?**

Johnson stopped rapamycin in 2024 after about five years. In a post on X he cited skin and soft-tissue infections, higher glucose and lipid levels and a raised resting heart rate, and concluded the side effects were not worth it.

**Does Bryan Johnson take statins?**

His published prescription list does not include a statin. He lowers LDL cholesterol and ApoB with evolocumab (Repatha), an injection every two weeks, which in the FOURIER trial cut LDL by 59% on top of statins. For most people with high LDL, a statin is the usual first drug, chosen with a clinician.

**Can I follow Blueprint safely?**

Copy the exercise, the fixed sleep schedule and the plate: mostly plants, legumes, olive oil and enough protein. Do not copy the nine prescription drugs, which each need a prescriber who knows your history. Get labs through a clinician, and do not chase his quoted vitamin D or ferritin, which sit outside the usual lab range or near its low end.

## Sources

1. Johnson B. Blueprint protocol. protocol.bryanjohnson.com (accessed November 2026). <https://protocol.bryanjohnson.com/>
2. US Department of Health and Human Services. Physical Activity Guidelines for Americans, 2nd edition. Washington, DC: HHS; 2018. <https://health.gov/our-work/nutrition-physical-activity/physical-activity-guidelines>
3. Sabatine MS et al. Evolocumab and clinical outcomes in patients with cardiovascular disease (FOURIER). New England Journal of Medicine 2017;376:1713-1722. <https://www.nejm.org/doi/full/10.1056/NEJMoa1615664>
4. Mach F et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal 2020;41(1):111-188. <https://academic.oup.com/eurheartj/article/41/1/111/5556353>
5. Waziry R et al. Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial. Nature Aging 2023;3:248-257. <https://www.nature.com/articles/s43587-022-00357-y>
6. Higgins-Chen AT et al. A computational solution for bolstering reliability of epigenetic clocks: implications for clinical trials and longitudinal tracking. Nature Aging 2022;2:644-661. <https://www.nature.com/articles/s43587-022-00248-2>
7. Belsky DW et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife 2022;11:e73420. <https://doi.org/10.7554/eLife.73420>
8. Watson NF et al. Recommended amount of sleep for a healthy adult: a joint consensus statement of the American Academy of Sleep Medicine and Sleep Research Society. Sleep 2015;38(6):843-844. <https://doi.org/10.5665/sleep.4716>
9. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2025. Diabetes Care 2025;48(Suppl 1):S27-S49. <https://diabetesjournals.org/care/article/48/Supplement_1/S27/157566>
10. Pearson TA et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice. A statement for healthcare professionals from the CDC and the AHA. Circulation 2003;107:499-511. <https://doi.org/10.1161/01.CIR.0000052939.59093.45>
11. Demay MB et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2024;109(8):1907-1947. <https://doi.org/10.1210/clinem/dgae290>
12. NIH Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. <https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/>
13. Estruch R et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts (PREDIMED). New England Journal of Medicine 2018;378:e34. <https://doi.org/10.1056/NEJMoa1800389>
14. US Food and Drug Administration. Important information about young donor plasma infusions for profit. February 2019. <https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/important-information-about-young-donor-plasma-infusions-profit>
15. Skulas-Ray AC et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation 2019;140:e673-e691. <https://doi.org/10.1161/CIR.0000000000000709>
16. SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine 2015;373:2103-2116. <https://doi.org/10.1056/NEJMoa1511939>
17. Kreider RB et al. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition 2017;14:18. <https://doi.org/10.1186/s12970-017-0173-z>
18. American College of Radiology. ACR statement on screening total body MRI. 2023. <https://www.acr.org/News-and-Publications/Media-Center/2023/ACR-Statement-on-Screening-Total-Body-MRI>
19. Ross AC et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. Journal of Clinical Endocrinology and Metabolism 2011;96(1):53-58. <https://doi.org/10.1210/jc.2010-2704>
20. Holick MF et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2011;96(7):1911-1930. <https://doi.org/10.1210/jc.2011-0385>
